Abcam Plc (LON:ABC) has been assigned an average rating of “Hold” from the six research firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has issued a buy recommendation on the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is GBX 1,031.20 ($13.88).

Several research firms recently commented on ABC. Peel Hunt increased their price objective on Abcam from GBX 750 ($10.09) to GBX 1,020 ($13.73) and gave the company a “hold” rating in a research report on Wednesday, September 20th. J P Morgan Chase & Co reaffirmed a “neutral” rating and set a GBX 864 ($11.63) price objective on shares of Abcam in a research report on Tuesday, September 12th. Numis Securities increased their price objective on Abcam from GBX 1,116 ($15.02) to GBX 1,200 ($16.15) and gave the company an “add” rating in a research report on Tuesday, September 12th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 1,100 ($14.80) price objective on shares of Abcam in a research report on Monday, September 11th. Finally, Panmure Gordon reissued a “sell” rating on shares of Abcam in a report on Monday, September 11th.

Abcam (LON:ABC) opened at GBX 1,000 ($13.46) on Thursday. Abcam has a twelve month low of GBX 9.73 ($0.13) and a twelve month high of GBX 1,113 ($14.98).

ILLEGAL ACTIVITY NOTICE: This news story was posted by Watch List News and is the sole property of of Watch List News. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.watchlistnews.com/abcam-plc-abc-receives-average-recommendation-of-hold-from-brokerages/1775440.html.

Abcam Company Profile

Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.

Analyst Recommendations for Abcam (LON:ABC)

Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.